62025TN0635
· Procedural documentAction brought on 18 September 2025 – Health Labs Care v EUIPO – NP Supplements Monoprosopi (NPhealthLABS +)
(Case T-635/25)
(C/2025/5861)
Language in which the application was lodged: English
Parties
Applicant: Health Labs Care S.A. (Warsaw, Poland) (represented by: M. Stępkowski, lawyer)
Defendant: European Union Intellectual Property Office
Other party to the proceedings before the Board of Appeal: NP Supplements Monoprosopi I.K.E. (Athens, Greece)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Other party to the proceedings before the Board of Appeal
Trade mark at issue: European Union figurative mark NPhealthLABS + – Application for registration No 18 838 128
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 1 July 2025 in Case R 2471/2024-2
Form of order sought
The applicant claims that the Court should:
—
annul the contested decision;
—
in the alternative, alter the contested decision and uphold the appeal against the Opposition Division’s decision; and uphold the opposition in its entirety;
—
order EUIPO and the other party to the proceedings before the Board of Appeal to bear their own costs and to pay those incurred by the Applicant.
Pleas in law
—
Infringement of Article 8(4) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;
—
Infringement of Articles 94(1) and 95(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council in conjunction with Article 41(2)(a) of the Charter of Fundamental Rights of the European Union.